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Naturally occurring 2,7-anhydro-alpha-N-acetylneuraminic acid (2,7-anhydro-Neu5Ac) is a trans-
glycosylation product of bacterial intramolecular trans-sialidases (IT-sialidases). A facile one-pot two-
enzyme approach has been established for the synthesis of 2,7-anhydro-sialic acid derivatives including
those containing different sialic acid forms such as Neu5Ac and N-glycolylneuraminic acid (Neu5Gc). The
approach is based on the use of Ruminoccocus gnavus IT-sialidase for the release of 2,7-anhydro-sialic
acid from glycoproteins, and the conversion of free sialic acid by a sialic acid aldolase. This synthetic
method, which is based on a membrane-enclosed enzymatic synthesis, can be performed on a prepar-
ative scale. Using fetuin as a substrate, high-yield and cost-effective production of 2,7-anhydro-Neu5Ac
was obtained to high-purity. This method was also applied to the synthesis of 2,7-anhydro-Neu5Gc. The
membrane-enclosed multienzyme (MEME) strategy reported here provides an efﬁcient approach to
produce a variety of sialic acid derivatives.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Sialic acids constitute a structurally diverse family of nine-
carbon acidic monosaccharides commonly found at the termini of
the glycan chains on glycoproteins and glycolipids [1]. N-Ace-
tylneuraminic acid (Neu5Ac), N-glycolylneuraminic acid (Neu5Gc),
and 2-keto-3-deoxy-D-glycero-D-galacto-nonulosonic acid (KDN)
are the three basic forms of sialic acids which are distinguished
from one another by different substituents at carbon-5. Additional
modiﬁcations include for example acetylation, lactylation,
methylation, sulfation, resulting in more than 50 structurally
distinct sialic acids [2]. As the outermost carbohydrate residues,
sialic acids are critical recognition elements in a number of bio-
logically important processes including cell-cell interaction, bac-
terial and viral infection, and tumor metastasis [3,4]. For example,
terminal sialic acid residues attached via a2, 3/6 glycosidic linkagesuge).
r Ltd. This is an open access articleto mucin glycan chains are prominent targets for commensal and
pathogenic bacteria [5e8].
The release of sialic acid by microbial sialidases allows the
bacteria present in the mucosal environment to access free sialic
acid for catabolism, unmask host ligands for adherence, participate
in bioﬁlm formation, modulate immune function by metabolic
incorporation, and expose the underlying glycans for further
degradation [7e10]. Most are hydrolytic sialidases, which release
free sialic acid from sialylated substrates. However, there are also
examples with transglycosylation activities. Intramolecular trans-
sialidase (IT-sialidase), represents a new class of sialidases recently
identiﬁed in pathogenic and commensal bacteria, releasing 2,7-
anydro-N-acetylneuraminic acid (2,7-anhydro-Neu5Ac) instead of
sialic acid [11e13]. Reaction speciﬁcity varies, with hydrolytic sia-
lidases demonstrating broad activity against a2,3-, a2,6- and a2,8-
linked substrates, whereas IT-sialidases appear speciﬁc for a2,3-
linked substrates [7]. Recently, an IT-sialidase, RgNanH, from the
gut symbiont Ruminoccocus gnavus was structurally and function-
ally characterised. This enzyme produces 2,7-anhydro-Neu5Ac
from a2,3-linked sialic acid glycoproteins or oligosaccharidesunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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metabolic substrate for R. gnavus strains expressing the IT-sialidase,
suggesting a role in the adaptation of gut symbionts to the mucosal
environment [15]. Previously, 2,7-anhydro-Neu5Ac had been
detected in rat urine [16] and humanwet cerumen (ear wax) [17]. It
was suggested that this unusual sialic acid derivative may have
bactericidal activity and/or could serve as a reservoir for sialic acids
in the biological systems [17,18].
At present, the biological signiﬁcance of naturally occurring 2,7-
anhydro-Neu5Ac in body ﬂuid and secretions is still largely un-
known. This is due to the lack of effective synthetic methods for its
production. Lifely et al. [19] showed that methanolysis of sialic acid
gave the methyl ester of 2,7-anhydro-Neu5Ac in addition to the
methyl ester ketoside of sialic acid. The ﬁrst directed synthesis of
2,7-anhydro-Neu5Ac was completed efﬁciently by intramolecular
glycosidation of the S-(1-phenyl-1H-tetrazol-5-yl) glycoside de-
rivative of Neu5Ac using silver triﬂate e bis(acetonitrile) palladiu-
m(II) chloride as a promoter [20]. More recently, the production of
2,7-anhydro-Neu5Ac was achieved using a leech IT-sialidase [21]
and 4-methylumbelliferyl Neu5Ac (4MU-Neu5Ac) as substrate us-
ing sequential puriﬁcation steps including precipitation, Folch
partitioning and Bio-Gel puriﬁcation [18].
Here we report a facile membrane-enclosed multienzyme
(MEME) approach for the preparative synthesis of 2,7-anhydro-
Neu5Ac (1) and 2,7-anhydro-Neu5Gc (2) from glycoproteins using
R. gnavus IT-sialidase (RgNanH) and a commercial sialic acid
aldolase-catalysed reaction in one pot (see Fig. 1). The MEME syn-
thesis offers several advantages over the existing synthetic
methods such as the improved yield, the fact that the synthesis is
scalable and that the route is greatly simpliﬁed (one step reaction).
In addition, the MEME offers a cheaper solution to obtain sialic acid
derivatives considering the cost of the starting material used in the
previously reported chemical or enzymatic synthesis. The synthesis
of 2,7-anhydro-Neu5Ac was achieved at high purity and in 20 mg
scale using fetuin as substrate. The use of Neu5Gc-richFig. 1. Overview of the reaction scheme. RgNanH hydrolyses a2,3-linked-Neu5Ac on fetuin, r
degraded into N-acetylmannosamine (ManNAc) and pyruvate by a sialic acid aldolase, whiglycoproteins as donor substrates for preparing 2,7-anhydro-
Neu5Gc is also described. Obtaining these compounds at a pre-
parative scale is crucial for studying the biological importance of
2,7-anhydro-sialic acid derivatives in the gut and their potential
applications in the biomedical sector.2. Materials and methods
2.1. Materials
Fetuin from bovine serum, asialofetuin (type II), bovine sub-
maxillary mucin, cytidine triphosphate, orcinol, CMP-sialic acid
synthetase from Neisseria meningitidis group B, a2,3-
sialyltransferase from Pasteurella multocida, ammonium formate
and Dowex 1 8 anion exchange resinwere purchased from Sigma
Aldrich (St Louis, USA). 4MU-Neu5Ac is from Toronto Research
Chemicals (ON, Canada). Sialic acid aldolase from Escherichia coli,
30-sialyllactose (30SL) and Neu5Gc were purchased from Carbo-
synth Limited (Compton, UK), BioGel P2 from Bio-Rad laboratories
and SnakeSkin™ Dialysis Tubing, 7 kDa molecular weight cut off
(MWCO), 22mm from Thermo Fisher Scientiﬁc (Hemel Hempstead,
UK). Nanopure water (18.2 MU cm; NanoPureThermo ﬁsher Barn-
stead Water Reverse osmosis Puriﬁcation System) was used for
buffer preparation and for puriﬁcation. RgNanH was produced and
puriﬁed as described previously [13]. 30-glycolylneuraminyllactose
(Neu5Gca2-3Lac) was synthesised as previously reported [22].2.2. Enzymatic synthesis of 2,7-anhydro-sialic acid
A dialysis membrane (7 kDa molecular weight cut off MWCO)
containing fetuin, modiﬁed asialofetuin or bovine submaxillary
mucin (15 mg/mL in 100 mM ammonium formate pH 6.5) was
incubated in 100 mM ammonium formate pH 6.5 for 2 h at 37 C
with gentle shaking (115 rpm). Following the addition of 50 nM
RgNanH (in Tris buffer 40 mM, pH 7.9) into the dialysis membrane,eleasing 2,7-anhydro-Neu5Ac as the major product but also Neu5Ac. Neu5Ac is further
ch is inactive against 2,7-anhydro-Neu5Ac.
M. Monestier et al. / Carbohydrate Research 451 (2017) 110e117112the reaction mixture was incubated in a new solution of 100 mM
ammonium formate (pH 6.5) at 115 rpm, 37 C for 24 h. Then 0.5
units/mL of sialic acid aldolase (in 100 mM ammonium formate pH
6.5) was added to the membrane enclosed reaction mixture.
Following a further 20 h incubation at 115 rpm and 37 C, the
dialysate (100 mL) was recovered, diluted with 100 mL of ultrapure
water and freeze dried. The membrane enclosed reaction mixture
was dialysed with 100 mL ultrapure water for 2 h and again over-
night with 115 rpm shaking and at 37 C. The water was recovered,
pooled with the dried dialysate and freeze dried. After complete
dryness, the powder was dissolved in 100 mL Nanopure water and
freeze dried again 3 times to remove volatile salts.
2.3. Puriﬁcation of 2,7-anhydro-sialic acid
The freeze-dried sample corresponding to crude 2,7-anhydro-
Neu5Ac was dissolved in ultrapure water (2 mL) and puriﬁed by
anion exchange chromatography using a Dowex 1  8 column. The
anion exchange resin was ﬁrst equilibrated with ultrapure water
(200 mL) before applying the sample. After washing with ultrapure
water (60 mL) and 1 mM ammonium formate (25 mL), 2,7-
anhydro-Neu5Ac was eluted with a gradient of ammonium
formate ranging from 5 mM to 50 mM (150 mL) and freeze dried.
After complete dryness, the powder was dissolved in ultrapure
water (100 mL) and freeze dried again 3 times to remove volatile
salts. 2,7-anhydro-Neu5Ac dissolved in ultrapure water (1.5 mL),
centrifuged and ﬁltered on a PTFE 0.45 mm membrane, was then
desalted by BioGel P2 size exclusion chromatography. The obtained
2,7-anhydro-Neu5Ac was collected and freeze dried.
2.4. Synthesis of N-glycolylneuraminic acid-modiﬁed fetuin
Asialofetuin (25 mg/mL) was suspended in 100 mM Tris-HCl pH
8.5 with Neu5Gc (1.96  105 mol, 9.8 mM) and cytidine triphos-
phate (CTP) (1 eq., 9.8 mM) was added. After addition of a CMP-
sialic acid synthetase from Neisseria meningitidis (1 UN, 0.5 UN/
ml) and an a2e3-sialyltransferase from Pasteurella multocida (0.2
UN, 0.1 UN/mL), the reaction medium was incubated for 24 h at
37 C under gentle shaking (115 rpm). The Neu5Gc disappearance
as well as intermediate formation were monitored by thin-layer
chromatography (TLC) using a 2:1:1 butanol/AcOH/water mobile
phase (vol/vol/vol) and orcinol sugar stain (17 mM orcinol in 2:15:1
concentrated sulphuric acid/ethanol/water, vol/vol/vol). The reac-
tion was stopped and the asialofetuin derivative was separated by
Folch partitioning using a 2:1 chloroform/MeOH solution (vol/vol).
The obtained precipitate was dried under nitrogen ﬂux, re-
suspended in 2 mL of ultrapure water and freeze dried. This
product was then dialysed in 100 mM ammonium formate pH 6.5
for 4 h at 37 C, 115 rpm, before performing the next step.
2.5. Analytical methods
For electrospray ionisation mass spectrometry (ESI-MS) anal-
ysis, 2,7-anhydro-Neu5Ac was dissolved in methanol (0.1 mg/mL)
and ﬁltered on a PTFE 0.45 mm membrane.
MS spectra were acquired on Expression CMSL (Advion, Ithaca,
USA) with ESI ionisation using direct injection operated in a
negative ionmode. Advion Data Express (version 2.2.29.2) software
package was used to evaluate the MS data.
For high resolution mass spectrometry analysis, the sample was
diluted into 50% methanol/0.5% NH4OH and infused into a Synapt
G2-Si mass spectrometer (Waters, Manchester, UK) at 5 mL/min
using a Harvard Apparatus syringe pump. The mass spectrometer
was controlled by Masslynx 4.1 software (Waters). It was operated
in high resolution and negative ion mode and calibrated usingsodium formate. The sample was analysed for 2 min with 1 s MS
scan time over the range of 50e600 m/z with 3.0 kV capillary
voltage, 40 V cone voltage, 100 C cone temperature. Leu-
enkephalin peptide (1 ng/mL, Waters) was infused at 10 mL/min as
a lock mass (m/z 554.262) and measured every 10 s. Spectra were
generated in Masslynx 4.1 by combining a number of scans, and
peaks were centred using automatic peak detection with lock mass
correction.
For Nuclear magnetic resonance (NMR) analysis, 2,7-anhydro-
Neu5Ac (5mg) or 2,7-anhydro-Neu5Gc (3mg, crude) was dissolved
in D2O (800 mL) and transferred into a 5 mm o.d. NMR tube for
spectral acquisition. NMR spectra were run on a 600 MHz Bruker
Avance III HD spectrometer (Bruker Biospin GmbH, Rheinstetten,
Germany) ﬁtted with a TCI cryoprobe and running Topspin 3.2
software. All experiments were performed at 300 K. 1H NMR
spectra were acquired using the noesygppr1d pulse sequence for
suppression of the residual water signal. Spectra were acquired
with 32678 complex points in the time domain, spectral width
20.5 ppm, acquisition time 2.67 s, relaxation delay 3.0 s and 64
scans. Fourier transformation was carried out with zero ﬁlling to
65536 points and exponential multiplication to give line broad-
ening of 0.3 Hz. A proton decoupled 13C spectrum of the same so-
lution was acquired at 151 MHz using the zgpg30 pulse sequence
with 32678 complex time domain points, spectral width
220.9 ppm, acquisition time 0.98 s, relaxation delay 2 s and 7200
scans. Fourier transformation was carried out with zero ﬁlling to
65536 points and exponential multiplication to give 3.0 Hz line
broadening. The spectra were referenced using an external stan-
dard of methanol (dC ¼ 51.43 ppm) in D2O. An HSQC spectrum of
the same sample was recorded with the hsqcetgpprsisp2.2 pulse
sequence with spectral widths of 12 ppm (1H) and 165 ppm (13C), a
2048 (t2) x 256 (t1) point acquisition matrix which was zero ﬁlled
to 2048  1024 on 2D Fourier transformation, and 16 scans per t1
experiment. For complete and unambiguous assignment of the
proton and carbon signal, we performed standard two-dimensional
NMR techniques such as COSY and HSQC. 13C signals were assigned
using the HSQC spectrum based on the known 1H chemical shifts.
For MS analysis of fetuin glycosylation, native asialofetuin or its
derivative (100 mg) was dissolved in 100 mL ammonium bicarbonate
(50 mM, pH 8) and heated to 100 C for 5 min. After cooling the
sample to room temperature, trypsin (20 mg) was added and the
reaction was incubated at 37 C for 16 h. Trypsin was heat inacti-
vated at 100 C for 5 min and PNGase F (8 IUB milliunits; New
England Biolabs) was added to the mixture. The reaction was
incubated at 37 C for 16 h. The released glycans were puriﬁed
using a C-18 Sep-Pak® cartridges, prewet with 3 vol of methanol
and equilibrated with 3 vol of 5% (vol/vol) acetic acid. Released
glycans were eluted with 3 vol of 5% acetic acid and freeze-dried.
The samples were dissolved in 200 mL of anhydrous DMSO, fol-
lowed by the addition of ~25 mg NaOH and 300 mL iodomethane.
The permethylation reaction was incubated at room temperature
for 60 min under vigorous shaking and quenched by the addition of
1 mL of 5% (vol/vol) acetic acid. The permethylated glycans were
puriﬁed using a Hydrophilic-Lipophilic Balanced (HLB) copolymer
Oasis cartridge (Waters, UK), prewet with 4 vol of methanol and
equilibrated with 5% (vol/vol) methanol in H2O. Salts and other
hydrophilic contaminants were washed with 5 vol of 5% methanol
and permethylated glycans eluted with 3 vol of 100%methanol. The
samples were dried under a gentle stream of nitrogen, dissolved in
10 mL of TA30 [30% (vol/vol) acetonitrile, 0.1% (vol/vol) triﬂuoro-
acetic acid] and mixed with equal amount of 2,5-dihydroxybenzoic
acid (DHB; Sigma-Aldrich, UK; 10 mg/mL in TA30), before spotted
onto an MTP 384 polished steel target plate (Bruker, UK). The
samples were analysed by MALDI-TOF, using the Bruker Autoﬂex™
analyzer mass spectrometer (Applied Biosystems, Indiana, USA) in
Table 1
1H and 13C NMR chemical shifts (ppm) of the 2,7-anhydro-sialic acid derivatives.
2,7-anhydro-Neu5Ac [21]
H-3ax H-3eq H-4 H-5 5-Ac H-6 H-7 H-8 H-9 H-90
H 2.17 2.01 3.92 3.95 2.04 4.54 4.43 3.54 3.76 3.59
2,7-anhydro-Neu5Ac obtained with MEME synthesis
H-3ax H-3eq H-4 H-5 5-Ac H-6 H-7 H-8 H-9 H-90
H 2.17 2.01 3.95 3.92 2.04 4.54 4.44 3.54 3.76 3.60
C 38.1 38.1 69.5 54.6 24.4 79.8 79.3 74.6 64.9 64.9
1H and 13C chemical shifts of 2,7-anhydro-Neu5Gc obtained with Neu5Gca2-
3Lac
H-3ax H-3eq H-4 H-5 5-Gc H-6 H-7 H-8 H-9 H-90
H 2.22 2.03 3.99 4.02 4.15 4.58 4.48 3.57 3.78 3.60
C 38.2 38.2 69.7 54.6 63.6 80.0 79.6 75.0 65.2 65.2
2,7-anhydro-Neu5Gc obtained with MEME synthesis
H-3ax H-3eq H-4 H-5 5-Gc H-6 H-7 H-8 H-9 H-90
H 2.20 2.01 3.97 4.0 4.13 4.57 4.46 3.55 3.76 3.63
C 38.3 38.3 69.8 54.6 63.9 80.2 79.8 74.9 65.2 65.2
NMR solvent was D2O and temperature 300 K. Spectra were transformed using the
Topspin NMR Suite software with a 0.3 Hz line broadening, and were manually
phased, baseline corrected, and referenced by setting water signal to 4.77 ppm.
Fig. 2. NMR spectra (600 MHz) of 2,7-anhydro-Neu5Ac obtained using a membrane enclos
and (B) Fetuin (15 mg/mL) þ RgNanH (50 nM) þ sialic acid aldolase (0.5 U/mL) (97% pure;
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For HPLC analysis of sialic acid content, asialofetuin and its
sialylated derivatives were spiked with 50 ng KDN. Sialic acid and
its derivatives were released by mild acid hydrolysis in acetic acid
(2 N) at 80 C for 3 h. The samples were dried using a Concentrator
Plus (Eppendorf, UK) centrifugal evaporator and dissolved in 50 mL
DMB labelling reagent [4,5-Methylenedioxy-1,2-phenylenediamine
dihydrochloride (14 mM), sodium hydrosulﬁte (37 mM), acetic acid
(2.8 M), b-mercaptoethanol (1.5 M)]. The labelling reaction was
incubated at 50 C for 2.5 h. The labelled samples were analysed by
HPLC using a Luna C18(2) column (250mm 4.6 mm, 5 mmparticle
size and 100 Å pore size; Phenomenex, UK). Solvent A was aceto-
nitrile, solvent B was methanol 50% vol/vol in H2O and solvent C
was H2O. The gradient used was 4% A,14% B and 82% C to 11% A,14%
B and 75% C, over 30 min. The excitation and emission wavelength
was 373 and 448 nm, respectively. Elution times of labelled sialic
acids were compared to known standards of Neu5Ac and Neu5Gc.
2.6. In vitro enzymatic activity assay
Substrates 30SL or 4MU-Neu5Ac were incubated at 4 mg/mL
with 1 nM RgNanH in 100mM ammonium formate for 24 h at 37 C.
The reaction was stopped by addition of an equal vol of ethanol
prior to Folch partitioning. Neu5Gca2-3Lac was incubated at
0.33 mg/mL with 60 nM RgNanH in 20 mM sodium phosphate
buffer (pH 6.5) containing 0.02mg/mL bovine serum albumin (BSA)ed synthesis with: (A) Fetuin (15 mg/mL) þ RgNanH (50 nM) (85% pure; 15% Neu5Ac);
<1% Neu5Ac).
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and the precipitated enzyme removed by centrifugation (17 000 g,
10 min, room temperature). In the case of all three substrates, a no-
enzyme control was also carried out.3. Results and discussion
3.1. Membrane-enclosed enzymatic synthesis of 2,7-anhydro-
Neu5Ac
Here we used the recombinant IT-sialidase (RgNanH) from
R. gnavus ATCC 29149 which produces 2,7-anhydro-Neu5Ac from
a2,3-linked Neu5Ac substrates [13], and commercially available
fetuinwhich contains about 8% inweight of a2,3-linked Neu5Ac for
the enzymatic biosynthesis of 2,7-anhydro-Neu5Ac (Fig. 1). A
Membrane Enclosed Enzymatic Catalysis (MEEC) approach [23]
was used to achieve rapid and efﬁcient recovery of the reaction
product. This technique is based on the containment of the soluble
enzyme in a dialysis membrane allowing the smaller product to
diffuse through and be more readily recovered in the reaction
buffer. Fetuin was chosen as a substrate as it is bulky and
commercially available, allowing for both the enzyme (RgNanH)
and its substrate (fetuin) to be enclosed in the same dialysis
membrane and therefore readily separated from the mono-
saccharide product [24]. The 2,7-anhydro-sialic acid derivative
recovered in the reaction buffer was further puriﬁed by size
exclusion chromatography on a Bio-gel P-2 column in order to
remove the salts. ESI-MS and 1H and 13C NMR spectroscopy wereFig. 3. (A) NMR spectra (600 MHz) of MEME RgNanH-catalysed reactionwith standards of La
phosphate, pH 6.5) without BSA. The control is the reaction incubated overnight in the same
)-MS spectra of the MEME RgNanH-catalysed reaction with bovine submaxillary mucin with
and 2,7-anhydro-Neu5Gc (m/z ¼ 306.1).used to monitor the purity of the reaction product. The mass
spectrum and 1H NMR spectrum were identical to that of 2,7-
anhydro-Neu5Ac obtained by methanolysis of Neu5Ac [19] or
following enzymatic reaction of 4MU-Neu5Ac with the leech IT-
sialidase [21] (Table 1; Fig. 2A, Fig. S1A). This process achieved
37% yield based on the 8% a2,3-linked sialic acid on fetuin and the
product purity. Further analysis of the fetuin recovered after the
synthesis revealed that its glycosylation pattern was similar to that
of asialofetuin, attesting completion of the reaction (data not
shown). However, the recovered product contained 85% 2,7-
anhydro-Neu5Ac and 15% free sialic acid (Neu5Ac), as determined
by 1H NMR (Fig. 2A). No Neu5Ac was detected in the control re-
action in absence of RgNanH, suggesting that no spontaneous
degradation of fetuin occurred under the synthesis conditions or
even after a prolonged period up to 50 h dialysis, as monitored by
ESI-MS (data not shown). The use of alternative substrates such as
30SL or 4MU-Neu5Ac did not affect the amount of free Neu5Ac
produced (Fig. S2). Together these data indicated that Neu5Ac may
be a by-product of the transglycosylation reaction.3.2. Coupling reaction of IT-sialidase and sialic acid aldolase
Considering the difﬁculty and the low efﬁciency of the separa-
tion of free Neu5Ac from 2,7-anhydro-Neu5Ac, a commercially
available sialic acid aldolase from E. coli was introduced into the
dialysis membrane with RgNanH and fetuin. Sialic acid aldolases
are efﬁcient biocatalysts that convert free Neu5Ac into N-acetyl-
mannosamine (ManNAc) and pyruvate [25]. Since 2,7-anhydro-c, Neu5Gc and Neu5Gca2-3Lac in overlay in the same buffer conditions (20 mM sodium
conditions as the MEME reaction (including BSA) but without enzyme present. (B) ESI(-
out any puriﬁcation step showing the production of 2,7-anhydro-Neu5Ac (m/z ¼ 290.1)
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shown), this enzyme was used to convert free sialic acid into
smaller and uncharged enzymatic products which were easily
eliminated using anion exchange chromatography on Dowex 1  8
resin (chloride form) prior to the size exclusion chromatography
step. The 2,7-anhydro-Neu5Ac obtained during this one pot
membrane-enclosed multienzyme (MEME) synthesis was about
96% pure, as shown by MS (Fig. S1B) and NMR (Fig. 2B), with a 33%
yield. The Neu5Ac amount was reduced to traces representing less
than 1%, and other impurities (3%) were identiﬁed as protein
residues.
The multi-step enzymatic synthesis developed here is efﬁcient,
low cost and scalable to at least 20 mg, and allows the recovery of
2,7-anhydro-Neu5Ac with high purity. This method is also appli-
cable to the synthesis of other 2,7-anhydro-sialic acid derivatives.Fig. 4. Analysis of the asialofetuin derivative after Neu5Gc enzymatic transfer. (A) Major olig
transfer characterised by MALDI-TOF; appearance of terminal Neu5Gc is observed after enz
asialofetuin derivative after Neu5Gc transfer as quantiﬁed by HPLC after derivatization usi
references to colour in this ﬁgure legend, the reader is referred to the web version of this3.3. Membrane-enclosed enzymatic synthesis of 2,7-anhydro-
Neu5Gc
The ability of the RgNanH to produce 2,7-anhydro-Neu5Gc was
ﬁrst assessed using Neu5Gca2-3Lac as substrate. Following an
overnight incubation at 37 C, the product of the reaction was
analysed by NMR, showing the disappearance of the Neu5Gca2-
3Lac, the release of lactose and Neu5Gc, and the formation of a 2,7-
anhydro compound similar to 2,7-anhydro-Neu5Ac by NMR
(Fig. 3A). This 2,7-anhydro derivative was further identiﬁed as 2,7-
anhydro-Neu5Gc by NMR (see Table 1) and by high resolution MS
(HR-ESI-MS(-): m/z 1Calcd [C11H16NO9]-: 306.08304; found:
306.0831). In order to scale up the reaction, a membrane-enclosed
synthesis was ﬁrst performed using bovine submaxillary mucin as
Neu5Gc donor, in place of fetuin which only displays a negligible
amount of Neu5Gc [26]. Submaxillary mucin is 9e17% sialylated,osaccharides chains on the asialofetuin before (red) and after (blue) Neu5Gc enzymatic
ymatic treatment. (B) Neu5Ac and Neu5Gc relative amount on fetuin, asialofetuin and
ng 1,2-diamino-4,5-methylenedioxybenzene (DMB) reagent. (For interpretation of the
article.)
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cially available glycoprotein, with Neu5Gc accounting for 15% of the
total sialic acid content [27]. Although 2,7-anhydro-Neu5Gc was
produced as monitored by ESI-MS (Fig. 3B), a large amount of 2,7-
anhydro-Neu5Ac was also present, and the two 2,7-anhydro de-
rivatives could not be efﬁciently separated. It is expected that using
porcine submaxillary mucin as donor would greatly improve 2,7-
anhydro-Neu5Gc yields as Neu5Gc represents 90% sialic acid [28],
although the reaction product would still contain some 2,7-
anhydro-Neu5Ac.3.4. Synthesis of Neu5Gc-enriched glycoprotein
In the absence of a commercially available glycoprotein con-
taining exclusively Neu5Gc, and to minimise 2,7-anhydro-Neu5Gc
contamination with the Neu5Ac derivative, we attempted to
transfer Neu5Gc onto an acceptor glycoprotein using a one-pot
two-step enzymatic synthesis developed by Chen et al. [29,30].
Asialofetuin was the most suitable acceptor as it contains 1.0% of
Neu5Ac and the Neu5Ac free sites are good acceptor sites for the
Neu5Gc transfer. We used a CMP-sialic acid synthase from Neisseria
meningitidis group B to activate Neu5Gc to CMP-Neu5Gc, and a
a2e3-sialyltransferase from Pasteurella multocida for the transfer of
the activated sialic acid onto the acceptor glycoprotein with an
a2,3-linkage. The obtained asialofetuin derivative was separated
from the by-products by Folch partitioning and characterised by
MALDI-TOF, showing the appearance of mono and di-sialylated
oligosaccharide chains terminated with Neu5Gc (Fig. 4A). The
relative amount of Neu5Gc and Neu5Ac on the asialofetuin deriv-
ative was further quantiﬁed by HPLC after derivatization with the
1,2-diamino-4,5-methylenedioxybenzene (DMB), using KDN as an
internal response factor. The total sialic acid content ranged from
86% Neu5Ac and 14% Neu5Gc in asialofetuin to 6% Neu5Ac and 94%
Neu5Gc after Neu5Gc transfer (Fig. 4B). This Neu5Gc-rich glyco-
protein was then used in the membrane-enclosed enzymatic syn-
thesis after dialysis in ammonium formate. The 2,7-anhydro-
Neu5Gc obtained was characterised by NMR, and the proﬁle found
identical to the one previously obtained with Neu5Gca2-3Lac as
substrate (Table 1). The only difference between the 2,7-anhydro-
Neu5Ac and the 2,7-anhydro-Neu5Gc is the absence of a signal for
the acetyl group at 2.07 ppm on the 2,7-anhydro-Neu5Gc, replaced
by a glycolyl one at 4.13 ppm.
In summary, we have developed a convenient and efﬁcient
membrane-enclosedmultienzyme (MEME) approach for producing
2,7-anydro-modiﬁed sialic acids in a pure form, starting from
readily available glycoproteins. The synthetic method reported
herein offers general and straightforward access to a class of sialic
acid derivatives recently discovered in the gut and shows promise
to assess the biological signiﬁcance and potential applications of
2,7-anydro-modiﬁed sialic acids in the context of drug discovery
and biomedical research.Acknowledgements
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